Trial Profile
Phase I Study To Determine The Safety Of Halofuginone In Patients With A Solid Progressive Tumor
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Halofuginone (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 16 Sep 2005 New trial record.